EMILY GULLEY: Open Payments
NPI 1568178333 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$199 in 11 payments from 9 companies in 2025. Trend: 2023 $94 · 2024 $433 · 2025 $199
Food & beverage: $199
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $55 |
| Janssen Pharmaceuticals, Inc | 1 | $32 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Actelion Pharmaceuticals US, Inc. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
Products named: Ozempic, SPRAVATO, Wegovy, BREZTRI, Auvelity, OPSUMIT, CAPLYTA, REXULTI.
Industry payments across NE — which companies pay providers there.
